5,825
Views
235
CrossRef citations to date
0
Altmetric
Review

The epidemiology of inflammatory bowel disease

&
Pages 942-951 | Received 27 Dec 2014, Accepted 29 Jan 2015, Published online: 17 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (29)

Helena O. Haugbo, Pasquale Klepp & Anders Verket. (2023) Ulcerative colitis and periodontitis – a cross-sectional pilot study from a Norwegian cohort. Acta Odontologica Scandinavica 0:0, pages 1-8.
Read now
Anna-Maija Puolanne, Sami Qadri, Tiina Vesterinen, Saara Hiltunen, Aaro Mustonen, Samu Kurki, Kaija-Leena Kolho, Johanna Arola & Martti Färkkilä. (2022) Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?. Scandinavian Journal of Gastroenterology 57:11, pages 1304-1311.
Read now
Charlotte W. Appel, Sarah Christine Pedersen, Amalie Søgaard Nielsen & Birgit Furstrand Larsen. (2022) Telemedicine based on patient-reported outcomes in management of patients with inflammatory bowel disease in a real-life setting – a before and after cohort study. Scandinavian Journal of Gastroenterology 57:7, pages 825-831.
Read now
Fengqian Chen, Qi Liu, Yang Xiong & Li Xu. (2021) Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. International Journal of Nanomedicine 16, pages 4225-4237.
Read now
Camilla Rye, Katrine Hass Rubin, Frederik Trier Moller, Mette Julsgaard, Tine Jess & Vibeke Andersen. (2021) Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard. Clinical Epidemiology 13, pages 335-344.
Read now
Wenjie Liu, Chunhui Wang, Lijuan Tang & Hui Yang. (2021) Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis. Immunological Investigations 50:8, pages 869-883.
Read now
Madeleine Dober, Antonina Mikocka-Walus, Subhadra Evans, Lauren Beswick, Catherine Emerson & Lisa Olive. (2021) Perspectives on an Acceptance and Commitment Therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms. Psychotherapy Research 31:5, pages 668-681.
Read now
Julia K. Copeland, Gary Chao, Shelley Vanderhout, Erica Acton, Pauline W. Wang, Eric I. Benchimol, Ahmed El-Sohemy, Ken Croitoru, Jennifer L. Gommerman & David S. Guttman. (2021) The Impact of Migration on the Gut Metagenome of South Asian Canadians. Gut Microbes 13:1.
Read now
Ángel Arias & Alfredo J. Lucendo. (2020) Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians. Expert Review of Gastroenterology & Hepatology 14:11, pages 1069-1082.
Read now
Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh, Péter Takács, András Borsi, Anita Bálint, Klaudia Farkas, Ágnes Milassin, Péter L. Lakatos, Tamás Szamosi & Tamás Molnár. (2020) Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016. Expert Opinion on Biological Therapy 20:4, pages 443-449.
Read now
Vendel A. Kristensen, Milada Cvancarova, Marte Lie Høivik, Bjørn Moum & Morten H. Vatn. (2020) Serological antibodies and surgery in a population-based inception cohort of Crohn’s disease patients – the IBSEN study. Scandinavian Journal of Gastroenterology 55:4, pages 436-441.
Read now
Sofie Coenen, Egon Nijns, Ellen Weyts, Patricia Geens, Bart Van den Bosch, Séverine Vermeire, Marc Ferrante, Kris Vanhaecht & Gert Van Assche. (2020) Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy. Scandinavian Journal of Gastroenterology 55:3, pages 287-293.
Read now
Fumi Varyani, Konstantinos Argyriou, Frank Phillips, Eirini Tsakiridou & Gordon William Moran. (2019) Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data. Drug Design, Development and Therapy 13, pages 4091-4105.
Read now
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan & Martti Färkkilä. (2019) Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study. Scandinavian Journal of Gastroenterology 54:7, pages 849-854.
Read now
Ching-Chi Yen, Yi-Chen Chen, Ming-Tsang Wu, Chia-Chi Wang & Yu-Tse Wu. (2018) Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. International Journal of Nanomedicine 13, pages 669-680.
Read now
Belinda Jackson & Peter De Cruz. (2018) Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Review of Gastroenterology & Hepatology 12:11, pages 1079-1100.
Read now
Eduard Brunet, Cristina Roig-Ramos, Emili Vela, Montserrat Clèries, Luigi Melcarne, Albert Villòria, Caridad Pontes & Xavier Calvet. (2018) Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis. Annals of Medicine 50:7, pages 613-619.
Read now
Yu-Sheng Zhang, Feng Wang, Shu-Xiang Cui & Xian-Jun Qu. (2018) Natural dietary compound naringin prevents azoxymethane/dextran sodium sulfate-induced chronic colorectal inflammation and carcinogenesis in mice. Cancer Biology & Therapy 19:8, pages 735-744.
Read now
Adrian A. Chrobak, Jarosław Nowakowski, Małgorzata Zwolińska-Wcisło, Dorota Cibor, Magdalena Przybylska-Feluś, Katarzyna Ochyra, Monika Rzeźnik, Alicja Dudek, Aleksandra Arciszewska, Marcin Siwek & Dominika Dudek. (2018) Associations between chronotype, sleep disturbances and seasonality with fatigue and inflammatory bowel disease symptoms. Chronobiology International 35:8, pages 1142-1152.
Read now
Carrie Falling, Simon Stebbings, G. David Baxter, Richard B. Gearry & Ramakrishnan Mani. (2018) Profile of musculoskeletal pain in patients with inflammatory bowel disease: a study protocol for assessing the multidimensional experience of self-reported pain. Physical Therapy Reviews 23:3, pages 227-235.
Read now
Anna Wickbom, Johan Bohr, Nils Nyhlin, Anders Eriksson, Annika Lapidus, Andreas Münch, Kjell-Arne Ung, Lina Vigren, Åke Öst & Curt Tysk. (2018) Microscopic colitis in patients with ulcerative colitis or Crohn’s disease: a retrospective observational study and review of the literature. Scandinavian Journal of Gastroenterology 53:4, pages 410-416.
Read now
Gregor Novak, Pieter Hindryckx, Reena Khanna, Vipul Jairath & Brian G. Feagan. (2017) The safety of vedolizumab for the treatment of ulcerative colitis. Expert Opinion on Drug Safety 16:4, pages 501-507.
Read now
Daniel Muthas, Anna Reznichenko, Clare A. Balendran, Gerhard Böttcher, Ib Groth Clausen, Carina Kärrman Mårdh, Tomas Ottosson, Mohib Uddin, Thomas T. MacDonald, Silvio Danese & Mark Berner Hansen. (2017) Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scandinavian Journal of Gastroenterology 52:2, pages 125-135.
Read now
Sabine Schmidt-Weitmann, Thomas Grischott, Peter Bauerfeind & Christiane Brockes. (2017) Medical online consultation service in gastroenterology at the University Hospital Zurich. Cogent Medicine 4:1.
Read now
Stefan Schreiber. (2015) An update on biosimilar drugs for inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 9:sup1, pages 1-3.
Read now
Stefan Schreiber, Julian Panés, ByoungOh Kwon, SeungSuh Hong & Laurent Peyrin-Biroulet. (2015) Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13. Expert Review of Gastroenterology & Hepatology 9:sup1, pages 5-15.
Read now

Articles from other publishers (206)

Geert D’Haens, Michael Eberhardson, Zeljko Cabrijan, Silvio Danese, Remco van den Berg, Mark Löwenberg, Gionata Fiorino, P Richard Schuurman, Göran Lind, Per Almqvist, Peder S Olofsson, Kevin J Tracey, Stephen B Hanauer, Ralph Zitnik, David Chernoff & Yaakov A Levine. (2023) Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study. Journal of Crohn's and Colitis.
Crossref
Aelita A. Kamalova, Marina A. Khanafina & Galina A. Garina. (2023) Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review). Pediatric pharmacology 20:4, pages 309-317.
Crossref
Ying-Kai Hung, Shang-Tse Ho, Ching-Yun Kuo & Ming-Ju Chen. (2023) Multiomics Strategy Reveals the Mechanism of Action and Ameliorating Effect of Deer Velvet Antler Water Extracts on DSS-Induced Colitis. Biomedicines 11:7, pages 1913.
Crossref
Muhammad Ali Muzammil, FNU Fariha, Tirath Patel, Rohab Sohail, Munesh Kumar, Ejaz Khan, Bushra Khanam, Satesh Kumar, Mahima Khatri, Giustino Varrassi & Prasanthi Vanga. (2023) Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation. Cureus.
Crossref
Elizabeth E. Marr, Thomas J. Mulhern, Michaela Welch, Philip Keegan, Celia Caballero-Franco, Bryce G. Johnson, Marion Kasaian, Hesham Azizgolshani, Timothy Petrie, Joseph Charest & Elizabeth Wiellette. (2023) A platform to reproducibly evaluate human colon permeability and damage. Scientific Reports 13:1.
Crossref
Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni, Melania Dovizio, Flavio Caprioli, Fernando Rizzello, Marco Daperno & Alessandro Armuzzi. (2023) Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting. Digestive and Liver Disease.
Crossref
Giacomo Fuschillo, Valerio Celentano, Matteo Rottoli, Guido Sciaudone, Antonietta Gerarda Gravina, Raffaele Pellegrino, Raffaele Marfella, Marco Romano, Francesco Selvaggi & Gianluca Pellino. (2023) Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis. Digestive and Liver Disease 55:5, pages 580-586.
Crossref
Jiawei Wan, Xiujuan Yu, Jiao Liu, Jing Li, Tingyang Ai, Cong Yin, Hong Liu & Rui Qin. (2023) A special polysaccharide hydrogel coated on Brasenia schreberi : preventive effects against ulcerative colitis via modulation of gut microbiota . Food & Function 14:8, pages 3564-3575.
Crossref
E. Yu. Chashkova, N. S. Korotaeva, V. E. Pak, E. G. Grigoryev, L. R. Shedoeva & N. V. Tungusova. (2023) Clinical and epidemiological aspects of ulcerative colitis in the Irkutsk region. Koloproktologia 22:1, pages 108-116.
Crossref
Alexandra (Sasha) Cook & Alexander Zill. (2023) Individual health status as a resource: Analyzing associations between perceived illness symptom severity, burnout, and work engagement among employees with autoimmune diseases. Applied Psychology.
Crossref
Guido Corradi, Leticia Leon, Cecilia Theirs, Eduardo García‐Garzón, Daniel Clemente & Juan Ramon Barrada. (2022) Negative experiences with public bathrooms and chronic illness‐related shame. Neurourology and Urodynamics 42:2, pages 539-546.
Crossref
Eunju Kim. (2023) Effects of natural mono- and di-saccharide as alternative sweeteners on inflammatory bowel disease: a narrative review. Korean Journal of Community Nutrition 28:3, pages 181.
Crossref
Amanda Flanagan, Susan M. Allsopp, Sam A. O'Connor, Jacinta Tobin, Casper Pretorius, Ian S. Brown, Sally Bell & A. James M. Daveson. (2022) High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday region. Internal Medicine Journal.
Crossref
Kristina Bertl, Johan Burisch, Nikolaos Pandis, Corinna Bruckmann, Björn Klinge & Andreas Stavropoulos. (2022) Periodontitis prevalence in patients with ulcerative colitis and Crohn's disease ‐ PPCC: A case–control study. Journal of Clinical Periodontology 49:12, pages 1262-1274.
Crossref
Shuo Yang, Jiacui Shang, Lijun Liu, Zongxin Tang & Xiangchen Meng. (2022) Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology. Food & Function 13:23, pages 12156-12169.
Crossref
E. V. Davydova, M. V. Osikov & N. V. Kaygorodtseva. (2022) Morphological and immunohistochemical changes in oxazolone-induced ulcerative colitis under ozone therapy. Ural Medical Journal 21:5, pages 33-40.
Crossref
M. V. Osikov & N. V. Kaygorodtseva. (2022) Effect of systemic ozone use on oxidative modification of lipids and proteins in the colon in experimental colitis. Ural Medical Journal 21:5, pages 26-32.
Crossref
Francesca Di Candido. (2022) Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery. Reviews on Recent Clinical Trials 17:4, pages 227-239.
Crossref
Olivier Fakih, Daniel Wendling, Frank Verhoeven & Clément Prati. (2022) World mortality of ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease in 2015 and its evolution from 2001 to 2015. Joint Bone Spine 89:6, pages 105452.
Crossref
Salvatore Magrì, Mauro Demurtas, Maria Francesca Onidi, Marcello Picchio, Walter Elisei, Manuela Marzo, Federica Miculan, Roberto Manca, Maria Pina Dore, Bianca Maria Quarta Colosso, Antonio Cicu, Luigi Cugia, Monica Carta, Laura Binaghi, Paolo Usai, Mariantonia Lai, Fabio Chicco, Massimo Claudio Fantini, Alessandro Armuzzi & Giammarco Mocci. (2022) Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study. World Journal of Clinical Cases 10:30, pages 10921-10930.
Crossref
Efe Sezgin, Gamze Terlemez, Berkay Bozkurt, Göksel Bengi, Hale Akpinar & İlker Büyüktorun. (2022) Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. PeerJ 10, pages e14217.
Crossref
Aleksandra Szymczak-Tomczak, Alicja Ewa Ratajczak, Marta Kaczmarek-Ryś, Szymon Hryhorowicz, Anna Maria Rychter, Agnieszka Zawada, Ryszard Słomski, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2022) Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine 11:19, pages 5715.
Crossref
Ananda Quaresma Nascimento, Diego Bessa Dantas, Giovana Salomão Melo, Fabiana de Campos Gomes & João Simão de Melo Neto. (2022) Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study. PLOS ONE 17:9, pages e0274572.
Crossref
Éva Boros, Zoltán Hegedűs, Zoltán Kellermayer, Péter Balogh & István Nagy. (2022) Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease. Frontiers in Immunology 13.
Crossref
Lu Zhang, Shuai Xiong, Fengchen Jin, Fan Zhou, Hongjun Zhou, Jinhong Guo, Chuanbiao Wen & Biao Huang. (2022) Global trends in intestinal flora and ulcerative colitis research during the past 10 years: A bibliometric analysis. Frontiers in Microbiology 13.
Crossref
Juanjuan Cheng, Xingdong Ma, Haitao Zhang, Xiaoyan Wu, Minhua Li, Gaoxiang Ai, Ruoting Zhan, Jianhui Xie, Ziren Su & Xiaoqi Huang. (2022) 8-Oxypalmatine, a novel oxidative metabolite of palmatine, exhibits superior anti-colitis effect via regulating Nrf2 and NLRP3 inflammasome. Biomedicine & Pharmacotherapy 153, pages 113335.
Crossref
Jiang-tao HouBin PengShi-jing ZhangYong-xin LuoYi-ming ChenJia-zhong CaiYi WenHong MiJian-feng LuoXiao-mei ZhengSi-min PanShi-ying Liu, Xin-lin ChenBin Chen. (2022) The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease. Palliative Medicine Reports 3:1, pages 154-161.
Crossref
Xiang Ting Goh, Suh Kuan Fong, Hwa Chia Chai, Boon Pin Kee & Kek Heng Chua. (2022) The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn’s disease. Gene 836, pages 146661.
Crossref
G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier & M. J. Pierik. (2022) Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems. Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems.
Yongchun Li, Lili Sheng, Prasant Kumar Jena, Miranda Claire Gilbert, Yu-Jui Yvonne Wan & Hua Mao. (2022) Retinoic Acid Signaling Is Compromised in DSS-Induced Dysbiosis. Nutrients 14:14, pages 2788.
Crossref
Gorm Roager Madsen, Rune Wilkens, Trine Boysen, Johan Burisch, Robert Bryant, Dan Carter, Krisztina Gecse, Christian Maaser, Giovanni Maconi, Kerri Novak, Carolina Palmela, Leizl Joy Nayahangan & Martin Grønnebæk Tolsgaard. (2022) The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey. Alimentary Pharmacology & Therapeutics 56:2, pages 263-270.
Crossref
Gareth P. Gilna, Rebecca A. Saberi, Christopher F. O'Neil, Walter A. Ramsey, Carlos T. Huerta, Amber H. Langshaw, Joshua P. Parreco, Juan E. Sola, Chad M. Thorson & Eduardo A. Perez. (2022) Disparities in utilization of laparoscopic colectomies in pediatric Crohn's disease✰. Journal of Pediatric Surgery 57:6, pages 1110-1114.
Crossref
Chuanqi Huang, Junli Dong, Lu Cheng, Haoran Ma, Fuqian Wang, Yan Feng, Shu Zhang, Yuling Li, Dan Zhang, Xiaoqi Jin, Xin Xiong, Jie Jiang, Bin Wu, Hongfeng Xu & Geng Zhang. (2022) Alkaloids from Aconitum carmichaelii Alleviates DSS-Induced Ulcerative Colitis in Mice via MAPK/NF-κB/STAT3 Signaling Inhibition. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-17.
Crossref
Franziska Weiß, Carolina Czichos, Lukas Knobe, Lena Voges, Christian Bojarski, Geert Michel, Michael Fromm & Susanne M. Krug. (2022) MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier. Cells 11:9, pages 1541.
Crossref
Xinrui Wang, Shuai Quan, Jingyang Li, Ying Liu, Huageng Sun, Jingze Zhang & Dailin Liu. (2022) Protective Effects of Grape Seed Proanthocyanidin Extract in Preventing DSS Induced Ulcerative Colitis Based on Pharmacodynamic, Pharmacokinetic and Tissue Distribution. Current Drug Metabolism 23:6, pages 496-505.
Crossref
Bradley A White, Guilherme Piovezani Ramos & Sunanda Kane. (2022) The Impact of Alcohol in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 28:3, pages 466-473.
Crossref
Fatemeh Zare, Ali Ramezankhani, Mohtasham Ghaffari & Soudabeh Yarmohammadi. (2022) The effect of educational empowerment interventions on IBD patients in worldwide: A systematic review of randomized clinical trials. ranian Journal of Health Education and Health Promotion 10:1, pages 93-108.
Crossref
Rita Yunusova, Irina Usmanova, Amina Ishmukhametova, Larisa Gerasimova, Yigal Granot, Elmina Kgarmanova, Rauza Khusnarizanova & Alina Sarvalieva. (2022) EXTRA-INTESTINAL MANIFESTATIONS OF CROHN DISEASE AND CHRONIC ULCERATIVE COLITIS IN THE ORAL CAVITY. Actual problems in dentistry 17:4, pages 32-38.
Crossref
Jing Xu, Hao-ming Xu, Mei-feng Yang, Yu-jie Liang, Quan-zhou Peng, Yuan Zhang, Cheng-mei Tian, Li-sheng Wang, Jun Yao, Yu-qiang Nie & De-feng Li. (2022) New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease. Frontiers in Pharmacology 13.
Crossref
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, Nitza Vara, Priyam Kumar & Narendra Kumar. (2022) Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022, pages 1-15.
Crossref
Yu‐Jin Jeong, Da Hyun Kim & Kwang‐Won Lee. (2021) Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium‐induced colitis mice . Journal of the Science of Food and Agriculture 102:1, pages 434-444.
Crossref
Ben Hamilton, Harry Green, Neel Heerasing, Peter Hendy, Lucy Moore, Neil Chanchlani, Gareth Walker, Claire Bewshea, Nicholas A Kennedy, Tariq Ahmad & James Goodhand. (2021) Incidence and prevalence of inflammatory bowel disease in Devon, UK. Frontline Gastroenterology 12:6, pages 461-470.
Crossref
Antonina Mikocka-Walus, Inna Hanlon, Madeleine Dober, Catherine Emerson, Lauren Beswick, Christian Selinger, Jo Taylor, Lisa Olive, Subhadra Evans & Catherine Hewitt. (2020) Lived experience in people with inflammatory bowel disease and comorbid anxiety and depression in the United Kingdom and Australia. Journal of Health Psychology 26:12, pages 2290-2303.
Crossref
Pedro M. Veloso, Raul Machado & Clarisse Nobre. (2021) Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 89-103.
Crossref
Xiao-Qi Ye, Jing Cai, Qiao Yu, Xiao-Cang Cao, Yan Chen, Mei-Xin Rao, Bai-Li Chen, Yao He, Zhi-Rong Zeng, Hao Chen, Yi-Mou Lin, Qian Cao, Min-Hu Chen & Sheng-Hong Zhang. (2021) Nomogram to predict primary non-response to infliximab in patients with Crohn’s disease: a multicenter study. Gastroenterology Report 9:4, pages 329-338.
Crossref
Thais Gagno Grillo, Ana Elisa Valencise Quaglio, Rodrigo Fedatto Beraldo, Talles Bazeia Lima, Julio Pinheiro Baima, Luiz Claudio Di Stasi & Ligia Yukie Sassaki. (2021) MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World Journal of Gastrointestinal Oncology 13:9, pages 995-1016.
Crossref
Jeremy Sanderson & Michael Paul Escudier. 2021. Burket's Oral Medicine. Burket's Oral Medicine 553 577 .
Yuan-Fang Zhou, Ning Sun, Shi-Rui Cheng, Xiao-Dong Deng, Xiang-Yin Ye, Zheng-Jie Li, Jun Zhou, Gui-Xing Xu, Yu-Zhu Qu, Liu-Yang Huang, Rui-Rui Sun & Fan-Rong Liang. (2021) Effectiveness and safety of acupuncture therapy for inflammatory bowel disease: a protocol of systematic review and meta-analysis. BMJ Open 11:8, pages e045090.
Crossref
Jessica Amankwah Osei, Juan Nicolás Peña-Sánchez, Sharyle A Fowler, Nazeem Muhajarine, Gilaad G Kaplan & Lisa M Lix. (2021) Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults. Journal of the Canadian Association of Gastroenterology 4:4, pages 186-193.
Crossref
Carrie Falling, Simon Stebbings, G. David Baxter, Richard B. Gearry & Ramakrishnan Mani. (2021) Criterion validity and discriminatory ability of the central sensitization inventory short form in individuals with inflammatory bowel diseases. Scandinavian Journal of Pain 21:3, pages 577-585.
Crossref
Christopher W.P. Hopkins, Nick Powell, Christine Norton, Jonathan L. Dumbrill, Bu’Hussain Hayee & Calum D. Moulton. (2021) Cognitive Impairment in Adult Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of the Academy of Consultation-Liaison Psychiatry 62:4, pages 387-403.
Crossref
Dorte Melgaard, Signe Westmark, Peter Thaysen Laurberg & Anne Lund Krarup. (2021) A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark Region. United European Gastroenterology Journal 9:6, pages 688-698.
Crossref
Chris M. Li & Zhibin Chen. (2021) Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Frontiers in Cell and Developmental Biology 9.
Crossref
Motasem Alkhayyat, Mohammad Abureesh, Arshpal Gill, George Khoudari, Mohannad Abou Saleh, Emad Mansoor & Miguel Regueiro. (2021) Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy. Inflammatory Bowel Diseases 27:7, pages 1052-1060.
Crossref
Katrine Carlsen, Nicoline Willum Frederiksen & Vibeke Wewer. (2021) Integration of eHealth Into Pediatric Inflammatory Bowel Disease Care is Safe: 3 Years of Follow-up of Daily Care. Journal of Pediatric Gastroenterology & Nutrition 72:5, pages 723-727.
Crossref
Carrie Falling, Simon Stebbings, G David Baxter, Corey A Siegel, Richard B Gearry, Jo Nijs & Ramakrishnan Mani. (2021) Symptoms of central sensitization in patients with inflammatory bowel diseases: a case-control study examining the role of musculoskeletal pain and psychological factors. Scandinavian Journal of Pain 21:2, pages 283-295.
Crossref
Rebecca Zingel, Jens Bohlken & Karel Kostev. (2021) Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study. Journal of Alzheimer's Disease 80:4, pages 1471-1478.
Crossref
E. V. Davydova, M. V. Osikov, A. E. Bakeeva & N. V. Kaigorodtseva. (2021) Autoimmune profile of rat blood in experimental ulcerative colitis. Russian Journal of Immunology 24:2, pages 209-214.
Crossref
Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2021) Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. Journal of Clinical Medicine 10:7, pages 1515.
Crossref
F. Juliao-Baños, F. Puentes, R. López, M.A. Saffon, G. Reyes, V. Parra, M.T. Galiano, M. Barraza, J. Molano, E. Álvarez, R. Corrales, L.E. Vargas, F. Gil, P. Álvarez, L. Limas, R. Prieto, P. Yance, F. Díaz, J. Bareño, Fabián Juliao-Baños, Mateo Arrubla, Joselyn Camargo, Fabián Puentes, Lázaro Arango, Rocío López, Rafael García, Belén Mendoza, María A. Saffon, Luis F. Roldan, Julio Zuleta, Gustavo Reyes, Viviana Parra, Cristian Flórez, Edilberto Nuñez, María T. Galiano, Marcos Barraza, Isabel C. Sanchez, Jenny L. Molano, Jorge I. Lizarazo, Iván Cuellar, Eligio Álvarez, Rubén Corrales, Fabio Gil, Luz E. Vargas, Patricia Álvarez, Luis M. Limas, Robín Prieto, Hernán Ballén, Lidsay Delgado, Paola Yance & Felha Díaz. (2021) Characterization of inflammatory bowel disease in Colombia: Results of a national register. Revista de Gastroenterología de México (English Edition) 86:2, pages 153-162.
Crossref
F. Juliao-Baños, F. Puentes, R. López, M.A. Saffon, G. Reyes, V. Parra, M.T. Galiano, M. Barraza, J. Molano, E. Álvarez, R. Corrales, L.E. Vargas, F. Gil, P. Álvarez, L. Limas, R. Prieto, P. Yance, F. Díaz, J. Bareño, Fabián Juliao-Baños, Mateo Arrubla, Joselyn Camargo, Fabián Puentes, Lázaro Arango, Rocío López, Rafael García, Belén Mendoza, María A. Saffon, Luis F. Roldan, Julio Zuleta, Gustavo Reyes, Viviana Parra, Cristian Flórez, Edilberto Nuñez, María T. Galiano, Marcos Barraza, Isabel C. Sanchez, Jenny L. Molano, Jorge I. Lizarazo, Iván Cuellar, Eligio Álvarez, Rubén Corrales, Fabio Gil, Luz E. Vargas, Patricia Álvarez, Luis M. Limas, Robín Prieto, Hernán Ballén, Lidsay Delgado, Paola Yance & Felha Díaz. (2021) Caracterización de la enfermedad inflamatoria intestinal en Colombia: resultados de un registro nacional. Revista de Gastroenterología de México 86:2, pages 153-162.
Crossref
Luz María Rodríguez, Grant Izmirlian & Patrick E. Young. (2021) A deeper dive into disparities in IBD: Data from the ACS NSQIP. The American Journal of Surgery 221:4, pages 666-667.
Crossref
Lanlan Pang, Heng-Yu Liu, Zhidong Liu, Jingyu Tan, Loungyuan Zhou, Yun Qiu, Xiaoqing Lin, Jinshen He, Xuehua Li, Sinan Lin, Subrata Ghosh, Ren Mao & Minhu Chen. (2021) Role of Telemedicine in Inflammatory Bowel Disease: a Systematic Review and Meta-analysis of Randomized Clinical Trials (Preprint). Journal of Medical Internet Research.
Crossref
M.V. Gryaznova, S.A. Solodskikh, A.V. Panevina, M.Y. Syromyatnikov, Yu.D. Dvoretskaya, T.N. Sviridova, E.S. Popov & V.N. Popov. (2021) Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia. Heliyon 7:3, pages e06432.
Crossref
Orla Hennessy, Laurence Egan & Myles Joyce. (2021) Subtotal colectomy in ulcerative colitis—long term considerations for the rectal stump. World Journal of Gastrointestinal Surgery 13:2, pages 198-209.
Crossref
Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley & Kulmira Nurgali. (2021) Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis. Inflammatory Bowel Diseases 27:3, pages 388-406.
Crossref
Alicja Ewa Ratajczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2021) Do Only Calcium and Vitamin D Matter? Micronutrients in the Diet of Inflammatory Bowel Diseases Patients and the Risk of Osteoporosis. Nutrients 13:2, pages 525.
Crossref
Yan Li, Yuan‐Yi Zhang, Li‐Teng Yang, Jiang‐Qi Liu, Chuan Zhou, Zhi‐Qiang Liu, Gui Yang, Li‐Hua Mo, Zhi‐Gang Liu, Bai‐Sui Feng & Ping‐Chang Yang. (2020) FcγRI plays a critical role in patients with ulcerative colitis relapse. European Journal of Immunology 51:2, pages 459-470.
Crossref
Cyrla Zaltman, Rogério Serafim Parra, Ligia Yukie Sassaki, Genoile Oliveira Santana, Maria de Lourdes Abreu Ferrari, Sender J Miszputen, Heda M B S Amarante, Roberto Luiz Kaiser Junior, Cristina Flores, Wilson R Catapani, José Miguel Luz Parente, Mauro Bafutto, Odery Ramos, Carolina D Gonçalves, Isabella Miranda Guimaraes, Jose J R da Rocha, Marley R Feitosa, Omar Feres, Rogerio Saad-Hossne, Francisco Guilherme Cancela Penna, Pedro Ferrari Sales Cunha, Tarcia NF Gomes, Rodrigo Bremer Nones, Mikaell Alexandre Gouvea Faria, Mírian Perpétua Palha Dias Parente, António S Scotton, Rosana Fusaro Caratin, Juliana Senra & Júlio Maria Chebli. (2021) Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil. World Journal of Gastroenterology 27:2, pages 208-223.
Crossref
Adam SadowskiCorina DunlapAlison LacombeDouglas Hanes. (2021) Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clinical and Translational Gastroenterology 12:1, pages e00275.
Crossref
Fabian Juliao-Baños, Joshua Kock, Mateo Arrubla, Omar Calixto, Joselyn Camargo, Lina Cruz, Juan Hurtado, Absalon Clavijo, Jorge Donado, Seth Schwartz, Maria T. Abreu & Oriana M. Damas. (2021) Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Medicine 100:7, pages e24729.
Crossref
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Nadia Zandi, Benyamin Pazoki, Atiyeh Rezaei, Mehrnoosh Hashemi, Saeideh Momtaz, Roja Rahimi, Maryam Shayan, Ahmad Reza Dehpour & Amir Hossein Abdolghaffari. (2021) Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Molecular Biology Reports 48:1, pages 855-874.
Crossref
Eden Mariam Jacob, Ankita Borah, Sindhu C Pillai & D. Sakthi Kumar. (2020) Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials 10:12, pages 2460.
Crossref
Carlos Henrique Marques dos Santos, Amanda Cristine Alcântara Galindo, Bárbara Alencar da Silva, Camila Rodrigues Dantas, Isadora Albuquerque de Araújo Guilherme, José Elias Basmage Nunes Gomes, Kayque Michel Dallacqua, Mariana Pereira de Souza & Patricia Szlachta Senna. (2021) Comparative analysis of anxiety and depression prevalence between individuals with and without inflammatory bowel disease. Journal of Coloproctology 40:04, pages 339-344.
Crossref
Fabian Juliao-Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, William Otero Regino.María Teresa Galiano de Sánchez.Rafael García Duperly.María Teresa Vallejo O.Marcela Torres Amaya.. (2020) Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta. Revista Colombiana de Gastroenterología 35:Supl. 2, pages 63-200.
Crossref
Lauren J. Mohan, Lauren McDonald, Jacqueline S. Daly & Zebunnissa Ramtoola. (2020) Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier. Pharmaceutics 12:11, pages 1114.
Crossref
Dubravka Holik, Atila Bezdan, Monika Marković, Želimir Orkić, Andrea Milostić-Srb, Štefica Mikšić & Aleksandar Včev. (2020) The Association between Drinking Water Quality and Inflammatory Bowel Disease—A Study in Eastern Croatia. International Journal of Environmental Research and Public Health 17:22, pages 8495.
Crossref
Eunju Kim, Yerin Kim, Jihye Lee, Jae-Ho Shin, Pu Reum Seok, Yuri Kim & Sang-Ho Yoo. (2020) Leucrose, a natural sucrose isomer, suppresses dextran sulfate sodium (DSS)-induced colitis in mice by regulating macrophage polarization via JAK1/STAT6 signaling. Journal of Functional Foods 74, pages 104156.
Crossref
Sara Jarmakiewicz-Czaja, Aneta Sokal & Rafał Filip. (2020) What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?. Nutrients 12:10, pages 3073.
Crossref
Semih KALYON, Yasemin GÖKDEN & Fırat OYMAN. (2020) A new biological marker in inflammatory bowel disease: Pentraxin 3. Journal of Surgery and Medicine 4:10, pages 875-878.
Crossref
Hai-Feng Yun, Rui Liu, Dan Han, Xin Zhao, Jin-Wei Guo, Feng-Jiao Yan, Chuan Zhang, Hong-Wen Sun, Guo-Qiang Liang & Guo-Xing Zhang. (2020) Pingkui Enema Alleviates TNBS-Induced Ulcerative Colitis by Regulation of Inflammatory Factors, Gut Bifidobacterium, and Intestinal Mucosal Barrier in Rats. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-10.
Crossref
Rebecca Veca, Christian O’Dea, Jarred Burke, Eva Hatje, Anna Kuballa & Mohammad Katouli. (2020) A Comparative Study of the Adherent-Invasive Escherichia coli Population and Gut Microbiota of Healthy Vegans versus Omnivores. Microorganisms 8:8, pages 1165.
Crossref
F A De Voogd, A Mookhoek, K B Gecse, G De Hertogh, W A Bemelman, C J Buskens & G R D’Haens. (2020) Systematic Review: Histological Scoring of Strictures in Crohn’s Disease. Journal of Crohn's and Colitis 14:6, pages 734-742.
Crossref
Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao & Wei Zhou. (2020) Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study. International Journal of Surgery 79, pages 294-299.
Crossref
Éva Boros, Bence Prontvai, Zoltán Kellermayer, Péter Balogh, Patrícia Sarlós, Áron Vincze, Csaba Varga, Zoltán Maróti, Balázs Bálint & István Nagy. (2020) Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 10:7, pages 974.
Crossref
Aida Kamalian, Masoud Sohrabi Asl, Mahsa Dolatshahi, Khashayar Afshari, Shiva Shamshiri, Nazanin Momeni Roudsari, Saeideh Momtaz, Roja Rahimi, Mohammad Abdollahi & Amir Hossein Abdolghaffari. (2020) Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World Journal of Gastroenterology 26:24, pages 3365-3400.
Crossref
Tiziana Larussa, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Dan L. Dumitrascu, Ludovico Abenavoli & Francesco Luzza. (2020) Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian Survey. Reviews on Recent Clinical Trials 15:2, pages 137-144.
Crossref
MV Osikov, EV Davydova, MS Boyko, AE Bakeeva, NV Kaygorodtseva, IR Galeeva, AA Fedosov, MA Ilyinyh & LV Vorgova. (2020) Aspects of free radical oxidation in the large bowel in ulcerative colitis and Crohn’s disease. Bulletin of Russian State Medical University:(3)2020, pages 58-64.
Crossref
Laura Maria Minordi, Luigi Larosa, Gianfranco Belmonte, Franco Scaldaferri, Andrea Poscia, Antonio Gasbarrini & Riccardo Manfredi. (2020) Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. Clinical Imaging 62, pages 1-9.
Crossref
Radha Gadhok, Hannah Gordon, Gregory Sebepos-Rogers, Samantha Baillie, Saniath Akbar, Jane E. Abbott, Emma Michael, Omer F. Ahmad, Ben Cooper & James O. Lindsay. (2019) UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients. Digestive Diseases and Sciences 65:6, pages 1790-1799.
Crossref
Ivan Qi Han Ngui, Agampodi Promoda Perera & Rajaraman Eri. (2020) Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?. Molecules 25:10, pages 2427.
Crossref
Huimin Yan, Xinyu Zhang & Yi Xu. (2020) Aberrant expression of miR-21 in patients with inflammatory bowel disease. Medicine 99:17, pages e19693.
Crossref
Maria Chiara Mentella, Franco Scaldaferri, Marco Pizzoferrato, Antonio Gasbarrini & Giacinto Abele Donato Miggiano. (2020) Nutrition, IBD and Gut Microbiota: A Review. Nutrients 12:4, pages 944.
Crossref
Dandan Wang, Duoduo Xu, Yanqiu Zhang, Daqing Zhao & Mingxing Wang. (2020) A novel oligosaccharide isolated from Hericium erinaceus and its protection against LPS‐induced Caco‐2 cells via the TLR4/NF‐κB pathway . Journal of Food Biochemistry 44:3.
Crossref
Lisa S. Olive, Catherine A. Emerson, Eliza Cooper, Emily M. Rosenbrock & Antonina A. Mikocka-Walus. (2020) Fatigue, Physical Activity, and Mental Health in People Living With Inflammatory Bowel Disease, Fibromyalgia, and in Healthy Controls. Gastroenterology Nursing 43:2, pages 172-185.
Crossref
C. Schineis, K. S. Lehmann, J. C. Lauscher, K. Beyer, L. Hartmann, G. A. Margonis, J. Michel, C. E. Degro, F. N. Loch, F. Speichinger, M. E. Kreis & C. Kamphues. (2019) Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors. International Journal of Colorectal Disease 35:3, pages 387-394.
Crossref
Lin Yuan, Tsung-Teh Wu, Vishal Chandan, Yajue Huang & Lizhi Zhang. (2020) Clinicopathological significance of lymphocytic colitis/collagenous colitis in inflammatory bowel disease. Human Pathology 96, pages 87-95.
Crossref
Yanzhuo Su & Haomin Zhao. (2020) Predisposition of Inflammatory Bowel Disease Is Influenced by <b><i>IL-8</i></b>, <b><i>IL-10</i></b>, and <b><i>IL-18</i></b> Polymorphisms: A Meta-Analysis. International Archives of Allergy and Immunology 181:10, pages 799-806.
Crossref
Carrie L. Falling, Simon Stebbings, David G. Baxter, Richard B. Gearry & Ramakrishnan Mani. (2019) Central Sensitization Inventory Mediates the Relationship Between Inflammatory Bowel Disease Activity and Worse Musculoskeletal Pain Experiences. Pain Practice 20:1, pages 24-33.
Crossref
Peng-Bo Wu, Rao Qian, Chai Hong, Yi-tian Guo, Yuan-jie Yu, Guo Zhang & Shi-Yun Tan. (2020) Association between PTGER4 polymorphisms and inflammatory bowel disease risk in Caucasian. Medicine 99:34, pages e19756.
Crossref
Daniel G. Fernández-Ávila, Santiago Bernal-Macías, Viviana Parra-Izquierdo, Diana N. Rincón-Riaño, Juan M. Gutiérrez & Diego Rosselli. (2020) Prevalence of inflammatory bowel disease and related arthritis in Colombia, according to information from the Health and Social Protection Data System. Revista Colombiana de Reumatología (English Edition) 27:1, pages 3-8.
Crossref
Daniel G. Fernández-Ávila, Santiago Bernal-Macías, Viviana Parra-Izquierdo, Diana N. Rincón-Riaño, Juan M. Gutiérrez & Diego Rosselli. (2020) Prevalencia en Colombia de la enfermedad inflamatoria intestinal y el compromiso articular asociado, según información del Sistema Integral de Información de la Protección Social. Revista Colombiana de Reumatología 27:1, pages 3-8.
Crossref
Ritu Gothwal, Shailendra Tiwari, Shivendra Shivani & Manju Khurana. 2020. Intelligent Data Security Solutions for e-Health Applications. Intelligent Data Security Solutions for e-Health Applications 237 254 .
Shashi P. Singh, Hitendra S. Chand, Santanu Banerjee, Hemant Agarwal, Veena Raizada, Sabita Roy & Mohan Sopori. (2019) Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis. Digestive Diseases and Sciences 65:1, pages 141-149.
Crossref
A. I. Dolgushina, G. M. Khusainova, A. G. Vasilenko & V. A. Kononets. (2019) Prevalence of inflammatory bowel disease in the Chelyabinsk Region. Almanac of Clinical Medicine 47:6, pages 511-517.
Crossref
A.E. Dorofeyev, S.V. Golub, O.E. Ananin & Yu.Z. Dyni. (2019) Relationship modeling of biomarkers in assessing the activity of ulcerative colitis. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019:1, pages 129-133.
Crossref
Micol Artom, Wladyslawa Czuber-Dochan, Jackie Sturt, Hannah Proudfoot, Danniella Roberts & Christine Norton. (2019) Cognitive-behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial. Pilot and Feasibility Studies 5:1.
Crossref
Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy & Bander Balkhi. (2019) Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia. Cost Effectiveness and Resource Allocation 17:1.
Crossref
Katharina G. Eckert, Isabelle Abbasi-Neureither, Maximilian Köppel & Gerhard Huber. (2019) Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease – a scoping review and practical implications. BMC Gastroenterology 19:1.
Crossref
Sergei Bedrikovetski, Nagendra Dudi‐Venkata, Hidde M. Kroon, Jianliang Liu, Jane M. Andrews, Mark Lewis, Matthew Lawrence & Tarik Sammour. (2019) Systematic review of rectal stump management during and after emergency total colectomy for acute severe ulcerative colitis. ANZ Journal of Surgery 89:12, pages 1556-1560.
Crossref
Amy L. Lightner, Miguel Regueiro & Benjamin Click. (2019) Special Considerations for Colorectal Surgery in the Elderly IBD Patient. Current Treatment Options in Gastroenterology 17:4, pages 449-456.
Crossref
Adrian Goldiș, Raluca Lupușoru, Liana Gheorghe, Cristian Gheorghe, Anca Trifan, Daniela Dobru, Cristina Cijevschi, Alina Tanțău, Gabriel Constantinescu, Răzvan Iacob, Ramona Goldiș & Mircea Diculescu. (2019) Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania. Medicina 55:10, pages 704.
Crossref
Xiao-Qing Deng, Hong-Bo Zhang, Gui-Fang Wang, Dong Xu, Wen-Yan Zhang, Qiang-Song Wang & Yuan-Lu Cui. (2019) Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer. International Journal of Pharmaceutics 570, pages 118644.
Crossref
Radislav Nakov. (2019) New markers in ulcerative colitis. Clinica Chimica Acta 497, pages 141-146.
Crossref
Yan Tang, Yao Shi, Yifei Gao, Xiaomeng Xu, Ting Han, Jingxin Li & Chuanyong Liu. (2019) Oxytocin system alleviates intestinal inflammation by regulating macrophages polarization in experimental colitis. Clinical Science 133:18, pages 1977-1992.
Crossref
N. S. Robakidze & O. B. Shchukina. (2019) Pathogenetic Aspects of Oral Cavity Lesions in Inflammatory Gastrointestinal Tract Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology 29:4, pages 15-21.
Crossref
Jorrit L Opstelten, Ilonca Vaartjes, Michiel L Bots & Bas Oldenburg. (2019) Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study. Inflammatory Bowel Diseases 25:10, pages 1692-1699.
Crossref
Mia Jülke Røer, Milada Cvancarova Småstuen & Arne Gustav Røseth. (2019) Usability of IBDoc, a Novel Fecal Calprotectin Home-Based Rapid Test in Clinical Practice. Point of Care: The Journal of Near-Patient Testing & Technology 18:3, pages 85-91.
Crossref
C D Moulton, P Pavlidis, C Norton, S Norton, C Pariante, B Hayee & N Powell. (2019) Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?. Clinical and Experimental Immunology 197:3, pages 308-318.
Crossref
Carrie Falling, Simon Stebbings, G David Baxter & Ramakrishnan Mani. (2019) Central hypersensitivity – A model for persistent musculoskeletal pain in inflammatory bowel diseases. Medical Hypotheses 129, pages 109243.
Crossref
Jodi Cronin, Stephen Moore, Niamh Lenihan, Marion O’Shea & Noel Woods. (2018) The non-drug costs associated with the administration of an intravenous biologic treatment in the hospital setting. Irish Journal of Medical Science (1971 -) 188:3, pages 821-834.
Crossref
Daneng Wei, Lushuang Xie, Zhiqi Zhuang, Na Zhao, Biao Huang, Yong Tang, Shuguang Yu, Qizhi Zhou & Qiaofeng Wu. (2019) Gut Microbiota: A New Strategy to Study the Mechanism of Electroacupuncture and Moxibustion in Treating Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-16.
Crossref
Carrie Falling, Simon Stebbings, George D. Baxter, Richard B. Gearry & Ramakrishnan Mani. (2019) Musculoskeletal Pain in Individuals With Inflammatory Bowel Disease Reflects Three Distinct Profiles. The Clinical Journal of Pain 35:7, pages 559-568.
Crossref
Esther A. Hullah & Michael P. Escudier. (2019) The mouth in inflammatory bowel disease and aspects of orofacial granulomatosis. Periodontology 2000 80:1, pages 61-76.
Crossref
Mahsa Mahdipour, Afshin Shafaghi, Fariborz Mansour-Ghanaei, Amineh Hojati, Farahnaz Joukar & Sara Mavaddati. (2021) Fecal calprotectin role in diagnosis of ulcerative colitis and treatment follow-up. Journal of Coloproctology 39:02, pages 115-120.
Crossref
Maebh Kelleher, Raminder Singh, Caitriona M. O’Driscoll & Silvia Melgar. (2019) Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease. Cytokine & Growth Factor Reviews 47, pages 21-31.
Crossref
Rajesh Bhatia, Sern Wei Yeoh, Karl Vaz, Corrie Studd, Jarrad Wilson, Sally Bell, Petr Otahal & Alison Venn. (2019) Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia. Internal Medicine Journal 49:5, pages 622-630.
Crossref
Marin J de Jong, Danielle Roosen, Juliette H R J Degens, Tim R A van den Heuvel, Marielle Romberg-Camps, W Hameeteman, Alexander G L Bodelier, Igor Romanko, Milan Lukas, Bjorn Winkens, Tineke Markus, Ad A M Masclee, Astrid van Tubergen, Daisy M A E Jonkers & Marie J Pierik. (2019) Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 13:5, pages 555-563.
Crossref
Dana Duricova, Eva Dvorakova, Ondrej Hradsky, Katarina Mitrova, Marianna Durilova, Jana Kozeluhova, Pavel Kohout, Kristyna Zarubova, Jiri Bronsky, Nora Hradska, Eva Bronska, Miroslava Adamcova, Nadezda Machkova, Veronika Hruba, Martin Bortlik, Martin Lukas, Karin Malickova & Milan Lukas. (2019) Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation. Inflammatory Bowel Diseases 25:4, pages 789-796.
Crossref
Adérson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, Marcela Yumi Wada, Taciana Valéria Marcolino Silva & Flávio de Castro Feitosa. (2019) Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. World Journal of Gastroenterology 25:9, pages 1142-1157.
Crossref
Balázs Szirmay, András Tárnok, Patrícia Sarlós, Nóra Szigeti, Andrea Ludány, Péter Kustán, Zoltán Horváth‐Szalai, Attila Miseta & Tamás Kőszegi. (2018) Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease. European Journal of Clinical Investigation 49:3.
Crossref
Ester Navarro Correal, Olga Benítez Leiva, Angelina Dosal Galguera, Marta Gallego Barrero, Elena Sánchez Pastor & M. Francisca Murciano Gonzalo. (2019) Nurse-Led Telephone Advice Line for Patients With Inflammatory Bowel Disease. Gastroenterology Nursing 42:2, pages 133-139.
Crossref
Dandan Wang, Yanqiu Zhang, Shuang Yang, Daqing Zhao & Mingxing Wang. (2019) A polysaccharide from cultured mycelium of Hericium erinaceus relieves ulcerative colitis by counteracting oxidative stress and improving mitochondrial function. International Journal of Biological Macromolecules 125, pages 572-579.
Crossref
Johan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, Luisa Barros, Fernando Magro, Natalia Pedersen, Jens Kjeldsen, Zsuzsanna Vegh, Peter L Lakatos, Carl Eriksson, Jonas Halfvarson, Mathurin Fumery, Corinne Gower-Rousseau, Marko Brinar, Silvija Čuković-Čavka, Inna Nikulina, Elena Belousova, Sally Myers, Shaji Sebastian, Gediminas Kiudelis, Limas Kupcinskas, Doron Schwartz, Selwyn Odes, Ioannis P Kaimakliotis, Daniela Valpiani, Renata D’Incà, Riina Salupere, Stefania Chetcuti Zammit, Pierre Ellul, Dana Duricova, Martin Bortlik, Adrian Goldis, Hendrika Adriana Linda Kievit, Alina Toca, Svetlana Turcan, Jóngerð Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Ravi Misra, Naila Arebi, Pia Oksanen, Pekka Collin, Luisa de Castro, Vicent Hernandez, Ebbe Langholz & Pia Munkholm. (2019) Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study. Journal of Crohn's and Colitis 13:2, pages 198-208.
Crossref
Huijuan Wang, Shuhong Zhou, Jiahong Zhang, Shangwen Lei & Jing Zhou. (2019) Correlations between TLR polymorphisms and inflammatory bowel disease: a meta-analysis of 49 case-control studies. Immunologic Research 67:1, pages 142-150.
Crossref
Katarzyna Neubauer, Iwona Bednarz-Misa, Ewa Walecka-Zacharska, Jaroslaw Wierzbicki, Anil Agrawal, Andrzej Gamian & Malgorzata Krzystek-Korpacka. (2019) Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia. International Journal of Molecular Sciences 20:1, pages 166.
Crossref
Matteo Ruggeri & Francesca Romana Rolli. (2019) Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2019, pages 228424031882243.
Crossref
Nathan M. Solbak, Jian-Yi Xu, Jennifer E. Vena, Ala Al Rajabi, Sanaz Vaseghi, Heather K. Whelan & S Elizabeth McGregor. (2018) Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta’s Tomorrow Project participants stratified by risk. BMC Public Health 18:1.
Crossref
Adalberta Lima Martins, Rhaisa Almeida Volpato & Maria da Penha Zago-Gomes. (2018) The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterology 18:1.
Crossref
Paolo Governa, Maddalena Marchi, Veronica Cocetta, Bianca De Leo, Philippa Saunders, Daniela Catanzaro, Elisabetta Miraldi, Monica Montopoli & Marco Biagi. (2018) Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2. Pharmaceuticals 11:4, pages 126.
Crossref
Tomáš Douda. (2018) Vedolizumab, its pharmacological profile and therapeutic use. Klinická farmakologie a farmacie 32:3, pages 11-14.
Crossref
Katarzyna Neubauer, Barbara Woźniak-Stolarska & Małgorzata Krzystek-Korpacka. (2018) Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results. BioMed Research International 2018, pages 1-10.
Crossref
Alex Dregan. (2018) Cardiovascular disease risk and mortality within inflammatory bowel disorders: Opposing or congruent effects?. European Journal of Preventive Cardiology 25:15, pages 1621-1622.
Crossref
Vipul Jairath. (2018) Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis. American Journal of Gastroenterology 113:10, pages 1432-1434.
Crossref
Viviane Gomes NÓBREGA, Isaac Neri de Novais SILVA, Beatriz Silva BRITO, Juliana SILVA, Maria Carolina Martins da SILVA & Genoile Oliveira SANTANA. (2018) THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Arquivos de Gastroenterologia 55:3, pages 290-295.
Crossref
Daniele Maria-Ferreira, Adamara Machado Nascimento, Thales Ricardo Cipriani, Arquimedes Paixão Santana-Filho, Paulo da Silva Watanabe, Debora de Mello Gonçales Sant´Ana, Fernando Bittencourt Luciano, Karla Carolina Paiva Bocate, René M. van den Wijngaard, Maria Fernanda de Paula Werner & Cristiane Hatsuko Baggio. (2018) Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Scientific Reports 8:1.
Crossref
Alie Dijkstra, Anke Heida & Patrick Ferry van Rheenen. (2018) A Web-based Telemonitoring Strategy for Teenagers with IBD to Improve Efficiency of Care: Abandon or Ready for Sustained Adoption? (Preprint). Journal of Medical Internet Research.
Crossref
Elena Bolzacchini, Claudio Chini, Claudio Camillo Cortelezzi, Ilaria Vallini, Graziella Pinotti, Stefano La Rosa & Silvia Uccella. (2018) Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Tract in Long-Standing Ulcerative Colitis: Report of a Case and Review of the Literature. International Journal of Surgical Pathology 26:5, pages 479-483.
Crossref
Tyler S. Wahl, Fenil C. Patel, Lauren E. Goss, Daniel I. Chu, Jayleen Grams & Melanie S. Morris. (2018) The Obese Colorectal Surgery Patient: Surgical Site Infection and Outcomes. Diseases of the Colon & Rectum 61:8, pages 938-945.
Crossref
Éva Boros, Zoltán Kellermayer, Péter Balogh, Gerda Strifler, Andrea Vörös, Patrícia Sarlós, Áron Vincze, Csaba Varga & István Nagy. (2018) Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients . Mediators of Inflammation 2018, pages 1-11.
Crossref
S. Fischer, T. Rath & M. F. Neurath. (2018) Chronisch-entzündliche DarmerkrankungenInflammatory bowel diseases. Der Internist 59:7, pages 681-693.
Crossref
Levente Parragi, N Fournier, Jonas Zeitz, Michael Scharl, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, A M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann, Claudia Anderegg, Peter Bauerfeind, Christoph Beglinger, Stefan Begré, Dominique Belli, JoséM Bengoa, Luc Biedermann, Beat Bigler, Janek Binek, Mirjam Blattmann, Stephan Boehm, Jan Borovicka, Christian P Braegger, Nora Brunner, Patrick Bühr, Bernard Burnand, Emanuel Burri, Sophie Buyse, Matthias Cremer, Dominique H Criblez, Philippe de Saussure, Lukas Degen, Joakim Delarive, Christopher Doerig, Barbara Dora, Gian Dorta, Mara Egger, Tobias Ehmann, Ali El-Wafa, Matthias Engelmann, Jessica Ezri, Christian Felley, Markus Fliegner, Nicolas Fournier, Montserrat Fraga, Pascal Frei, Remus Frei, Michael Fried, Florian Froehlich, Christian Funk, Raoul Ivano Furlano, Suzanne Gallot-Lavallée, Martin Geyer, Marc Girardin, Delphine Golay, Tanja Grandinetti, Beat Gysi, Horst Haack, Johannes Haarer, Beat Helbling, Peter Hengstler, Denise Herzog, Cyrill Hess, Klaas Heyland, Thomas Hinterleitner, Philippe Hiroz, Claudia Hirschi, Petr Hruz, Rika Iwata, Res Jost, Pascal Juillerat, Vera Kessler Brondolo, Christina Knellwolf, Christoph Knoblauch, Henrik Köhler, Rebekka Koller, Claudia Krieger-Grübel, Gerd Kullak-Ublick, Patrizia Künzler, Markus Landolt, Rupprecht Lange, Frank Serge Lehmann, Andrew Macpherson, Philippe Maerten, Michel H Maillard, Christine Manser, Michael Manz, Urs Marbet, George Marx, Christoph Matter, Valérie McLin, Rémy Meier, Martina Mendanova, Christa Meyenberger, Pierre Michetti, Benjamin Misselwitz, Darius Moradpour, Bernhard Morell, Patrick Mosler, Christian Mottet, Christoph Müller, Pascal Müller, Beat Müllhaupt, Claudia Münger-Beyeler, Leilla Musso, Andreas Nagy, Michaela Neagu, Cristina Nichita, Jan Niess, Natacha Noël, Andreas Nydegger, Nicole Obialo, Carl Oneta, Cassandra Oropesa, Ueli Peter, Daniel Peternac, Laetitia Marie Petit, Franziska Piccoli-Gfeller, Julia Beatrice Pilz, Valérie Pittet, Nadia Raschle, Ronald Rentsch, Sophie Restellini, Jean-Pierre Richterich, Sylvia Rihs, Marc Alain Ritz, Jocelyn Roduit, Daniela Rogler, Gerhard Rogler, Jean-Benoît Rossel, Markus Sagmeister, Gaby Saner, Bernhard Sauter, Mikael Sawatzki, Michela Schäppi, Michael Scharl, Martin Schelling, Susanne Schibli, Hugo Schlauri, Sybille Schmid Uebelhart, Jean-François Schnegg, Alain Schoepfer, Frank Seibold, Mariam Seirafi, Gian-Marco Semadeni, David Semela, Arne Senning, Marc Sidler, Christiane Sokollik, Johannes Spalinger, Holger Spangenberger, Philippe Stadler, Michael Steuerwald, Alex Straumann, Bigna Straumann-Funk, Michael Sulz, Joël Thorens, Sarah Tiedemann, Radu Tutuian, Stephan Vavricka, Francesco Viani, Jürg Vögtlin, Roland Von Känel, Alain Vonlaufen, Dominique Vouillamoz, Rachel Vulliamy, Jürg Wermuth, Helene Werner, Paul Wiesel, Reiner Wiest, Tina Wylie, Jonas Zeitz & Dorothee Zimmermann. (2018) Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. Journal of Crohn's and Colitis 12:7, pages 811-818.
Crossref
Han Fang & Robert L. Judd. 2011. Comprehensive Physiology. Comprehensive Physiology 1031 1063 .
A.M. Villanueva Campos, G. Tardáguila de la Fuente, E. Utrera Pérez, C. Jurado Basildo, D. Mera Fernández & C. Martínez Rodríguez. (2018) Value of dual-energy CT enterography in the analysis of pathological bowel segments in patients with Crohn's disease. Radiología (English Edition) 60:3, pages 223-229.
Crossref
A.M. Villanueva Campos, G. Tardáguila de la Fuente, E. Utrera Pérez, C. Jurado Basildo, D. Mera Fernández & C. Martínez Rodríguez. (2018) Valor de la enterografía por tomografía computarizada con doble energía en el análisis de segmentos intestinales patológicos en pacientes con enfermedad de Crohn. Radiología 60:3, pages 223-229.
Crossref
Marin J. de Jong, Roxanne Huibregtse, Ad A.M. Masclee, Daisy M.A.E. Jonkers & Marie J. Pierik. (2018) Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review. Clinical Gastroenterology and Hepatology 16:5, pages 648-663.e3.
Crossref
Zhehui Zhu, Zubing Mei, Yuegui Guo, Guanghui Wang, Tingyu Wu, Ximao Cui, Zhenyu Huang, Yilian Zhu, Dongpeng Wen, Jinglve Song, Hailan He, Weimin Xu, Long Cui & Chenying Liu. (2018) Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 12:5, pages 546-558.
Crossref
Romy Lauche, Jon Wardle, Thomas Ostermann, Jon Adams, Jost Langhorst, Gustav Dobos, Andreas Michalsen & Holger Cramer. (2018) Characteristics of fasting users among internal medicine patients in Germany. Advances in Integrative Medicine 5:1, pages 29-34.
Crossref
Tomáš Douda. (2018) Aktuální možnosti biologické léčby idiopatických střevních zánětů - editorial. Vnitřní lékařství 64:3, pages 229-231.
Crossref
Uri Netz, Norman J. Galbraith, Stephen O'Brien, Jane Carter, Stephen Manek, Robert E. Petras & Susan Galandiuk. (2018) Long-term outcomes following ileal pouch-anal anastomosis in patients with indeterminate colitis. Surgery 163:3, pages 535-541.
Crossref
Petra Weimers & Pia Munkholm. (2018) The Natural History of IBD: Lessons Learned. Current Treatment Options in Gastroenterology 16:1, pages 101-111.
Crossref
Hai Yun Shi, Alexander N. Levy, Hirsh D. Trivedi, Francis K.L. Chan, Siew C. Ng & Ashwin N. Ananthakrishnan. (2018) Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clinical Gastroenterology and Hepatology 16:2, pages 190-197.e11.
Crossref
Fernando Magro & Tatiana António. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease 147 157 .
Anners Lerdal, Randi Opheim, Caryl L. Gay, Bjørn Moum, May Solveig Fagermoen & Anders Kottorp. (2017) Psychometric limitations of the 13-item Sense of Coherence Scale assessed by Rasch analysis. BMC Psychology 5:1.
Crossref
Xiaohong Lu, Yuanjie Yu & Shiyun Tan. (2017) p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis. BMC Gastroenterology 17:1.
Crossref
Raphael R. Fagundes & Cormac T. Taylor. (2017) Determinants of hypoxia-inducible factor activity in the intestinal mucosa. Journal of Applied Physiology 123:5, pages 1328-1334.
Crossref
Chen Diling, Yang Xin, Zheng Chaoqun, Yang Jian, Tang Xiaocui, Chen Jun, Shuai Ou & Xie Yizhen. (2017) Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota . Oncotarget 8:49, pages 85838-85857.
Crossref
James O. Lindsay, Alessandro Armuzzi, Javier P. Gisbert, Bernd Bokemeyer, Laurent Peyrin-Biroulet, Geoffrey C. Nguyen, Michael Smyth & Haridarshan Patel. (2017) Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease. Digestive and Liver Disease 49:10, pages 1086-1091.
Crossref
Sarah Fischer & Markus F. Neurath. (2017) Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics 102:4, pages 623-632.
Crossref
Marin J de Jong, Andrea E van der Meulen-de Jong, Mariëlle J Romberg-Camps, Marco C Becx, Jeroen P Maljaars, Mia Cilissen, Ad A van Bodegraven, Nofel Mahmmod, Tineke Markus, Wim M Hameeteman, Gerard Dijkstra, Ad A Masclee, Annelies Boonen, Bjorn Winkens, Astrid van Tubergen, Daisy M Jonkers & Marie J Pierik. (2017) Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. The Lancet 390:10098, pages 959-968.
Crossref
Bastien Dirrenberger, Isabelle Clerc-Urmès, Adeline Germain, Laurent Bresler, Pablo Olivera, Laura Martelli, Silvio Danese, Cédric Baumann, Valérie Laurent & Laurent Peyrin-Biroulet. (2017) Value of cross-sectional imaging in assessing active Crohn’s disease before stoma reversal. Digestive and Liver Disease 49:8, pages 864-871.
Crossref

Displaying 200 of 235 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.